The latest price target for Cardlytics (NASDAQ:CDLX) was reported by Northland Capital Markets on August 16, 2024. The analyst firm set a price target for $5.00 expecting CDLX to rise to within 12 months (a possible 28.87% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Cardlytics (NASDAQ:CDLX) was provided by Northland Capital Markets, and Cardlytics downgraded their market perform rating.

The last upgrade for Cardlytics Inc happened on March 15, 2024 when Craig-Hallum raised their price target to $18. Craig-Hallum previously had a hold for Cardlytics Inc.

The last downgrade for Cardlytics Inc happened on August 16, 2024 when Northland Capital Markets changed their price target from $7 to $5 for Cardlytics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardlytics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardlytics was filed on August 16, 2024 so you should expect the next rating to be made available sometime around August 16, 2025.

While ratings are subjective and will change, the latest Cardlytics (CDLX) rating was a downgraded with a price target of $7.00 to $5.00. The current price Cardlytics (CDLX) is trading at is $3.88, which is out of the analyst’s predicted range.